Stay updated on Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    Change Detected
    Summary
    The value on the webpage related to a phase II clinical trial for recurrent ovarian cancer has been updated from the previous treatment cycles schedule to a new treatment plan involving a combination of intensive locoregional intraperitoneal chemoimmunotherapy with cisplatin, rintatolimod, and pembrolizumab, followed by interval cytoreduction and consolidation therapy. The change signifies a shift in the treatment approach for patients with recurrent platinum-sensitive ovarian cancer, aiming to evaluate the effectiveness of this novel combination regimen.
    Difference
    1%
    Check dated 2024-06-06T14:23:32.000Z thumbnail image
  6. Check
    19 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to a detailed description of eligibility criteria, including examples such as general health condition or prior treatments. Additionally, specific inclusion criteria for patients have been outlined, such as age, type of cancer recurrence, and prior treatments.
    Difference
    53%
    Check dated 2024-05-22T20:22:26.000Z thumbnail image
  7. Check
    40 days ago
    Change Detected
    Summary
    The value 'Go to the classic website' has been updated to 'Site Map'. This change likely reflects an intervention related to medical and healthcare publications and documentation on the webpage.
    Difference
    0.8%
    Check dated 2024-05-01T18:44:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.